Brief: Acurx Pharmaceuticals Inc Reports Q1 2023 Results And Provides Business Update
12/05/2023 14:43
May 12 (Reuters) - Acurx Pharmaceuticals Inc ACXP.O :
* ACURX PHARMACEUTICALS, INC. REPORTS FIRST QUARTER 2023
RESULTS
AND PROVIDES BUSINESS UPDATE
* ACURX PHARMACEUTICALS INC - ENDED QUARTER WITH CASH
TOTALING
$7.2 MILLION
* ACURX PHARMACEUTICALS INC- QTRLY LOSS PER SHARE $0.25
Source text for Eikon: ID:nPn594wC4a
Further company coverage: ACXP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Acurx Pharmaceuticals
See all newsBrief: Acurx Pharmaceuticals Receives FDA Conditional Acceptance
Acurx Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Acurx Pharmaceuticals Q2 loss widens on higher R&D costs
Acurx Pharmaceuticals Inc expected to post a loss of 38 cents a share - Earnings Preview
Brief: FDA Provides Further Regulatory Guidance To Acurx Pharmaceuticals For The Ibezapolstat Clinical Development Program